Our screening showed that the gliomas with wide-type IDH (wt-IDH), especially in the GBM subtype, exerted an elevated GRPEL2 expression in contrast to IDH mutant (mt-IDH) gliomas and oligodendrogliomas (p < 0.001, Figure 2B). The gene discussed is GRPEL2; the disease is central nervous system cancer.